Brief: NewceIX CEO Issues Letter To Shareholders
04/11/2025 12:04
Nov 4 (Reuters) - NLS Pharmaceutics AG NCEL.O: NEWCELX CEO ISSUES LETTER TO SHAREHOLDERS NEWCELX- CO HAS $25 MILLION ELOC, WELL-CAPITALIZED FOR 12 MONTHS Source text: ID:nPn8Z2JDva Further company coverage: NCEL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on NewcelX AG
See all newsBrief: Newcelx Announces Pricing Of $1.4 Million Equity Financing At 20% Premium Pricing
Brief: Newcelx Submits Pre-IND Package To FDA For NCEL-101 For Treatment Of Type 1 Diabetes
Brief: Newcelx Updates Corporate Presentation To Highlight Type 1 Diabetes Flagship Program
U.S. STOCKS ON THE MOVE-Eli Lilly, Space stocks, Anixa Biosciences
U.S. STOCKS ON THE MOVE-Intel, Tempus AI, Boeing